ArticlePloS one2025
The epidemiology and risk factors of anal and oropharyngeal human papillomavirus (HPV) in males living with human immunodeficiency virus (HIV): A protocol for systematic review and meta-analysis.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeople living with human immunodeficiency virus (HIV) are more likely to be infected with human papillomavirus (HPV), which can lead to anal and oropharyngeal cancer in males, increasing the complexity of the disease.
objectiveThe aim of this study is to learn more about epidemiological data and factors influencing anal and oropharyngeal HPV infections in males with HIV through a systematic literature review in order to provide evidence for future interventions.
methodsThe PubMed, Embase, Web of Science, Cochrane Library, PsycINFO, and ClinicalTrials.gov databases will be searched from build to June 2024. Two researchers will independently carry out study selection, data extraction and risk of bias assessment. STATA 16.0 will be used to conduct meta-analysis. The estimated pooled prevalence of anal and oropharyngeal HPV (any HPV, high-risk HPV, low-risk HPV, type-specific HPV, and multiple HPV) in males living with HIV will be presented as percentage prevalence (p * 100%) with corresponding 95% confidence intervals (CI) by DerSimonian-Laird random-effect meta-analyses. Subgroup analysis will carried out by geographic region, income level, race, age, publication year, HPV genotyping, and risk factors (e.g., sexual behavior patterns). Risk factors and interventions-related dichotomous variables or continuous variables will be summarized as odds ratios (OR) and standardized mean differences, and reported through forest plots. The OR (greater than 1) shows an association (correlated). Heterogeneity will be assessed using the I2. Funnel plots, Begg and Egger tests will be applied to detect potential publication bias. PROSPERO REGISTRATION NUMBER: CRD42024579641.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.